(S)-V-0219 hydrochloride

• CAT Number: I041375
• Molecular Formula: C20H26ClF3N4O2
• Molecular Weight: 446.89
• Purity: ≥95%
• Synonyms: 4-[[(3S)-1-[[3-[4-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]methyl]piperidin-3-yl]methyl]morpholine;hydrochloride
• InChI: InChI=1S/C20H25F3N4O2.ClH/c21-20(22,23)17-5-3-16(4-6-17)19-24-18(29-25-19)14-27-7-1-2-15(13-27)12-26-8-10-28-11-9-26;/h3-6,15H,1-2,7-14H2;1H/t15-;/m0./s1
• InChIKey: PTRIYHLSBQMDQM-RSAXXLAASA-N
• SMILES: C1C[C@H](CN(C1)CC2=NC(=NO2)C3=CC=C(C=C3)C(F)(F)F)CN4CCOCC4.Cl

(S)-V-0219 hydrochloride（Cat No.:I041375）is a synthetic compound studied for its potential pharmacological applications, particularly in the treatment of neurological disorders. It is a selective agonist of specific receptors in the brain, which may have effects on cognitive function and neuroprotection. The “S” designation indicates the specific stereoisomer of V-0219, which is important for its targeted biological activity. Research into (S)-V-0219 hydrochloride focuses on its efficacy, safety, and potential therapeutic use in conditions like Alzheimer’s disease and other neurodegenerative disorders, aiming to develop novel treatments for cognitive decline.